Although patients with COVID-19 are known to present with constitutional and respiratory symptoms such as fever, cough, sore throat, and shortness of breath, there is growing evidence that these patients can also experience significant gastrointestinal symptoms such as nausea, vomiting, and diarrhea.
Researchers evaluated the association between diarrheagenic E coli and development of reactive arthritis and musculoskeletal symptoms among international travelers.
The prevalence of diverticulosis has been increasing, and research has demonstrated an increased risk of underlying colorectal cancer in this population.
The type and volume of intravenous supplementation required by patients with chronic intestinal failure could be indicators to categorize the severity of chronic intestinal failure.
Researchers sought to identify the incidence of hospital-acquired Clostridioides difficile infection and its associated length of stay in the United States.
The study researchers concluded that when compared with short-duration vancomycin therapy for the treatment of CDI, long-duration vancomycin therapy was associated with significantly lower CDI recurrence rates.
A report on the largest multistate produce-linked Shiga toxin-producing Escherichia coli outbreak in the United States highlighted challenges in determining the route of contaminated lettuce and in providing rapid, actionable guidance during an outbreak.
Study investigators concluded that the “values for bowel wall thickness reported in this systematic review can be used as guidance when screening for bowel-related pathology.
Pediatric patients with newly diagnosed celiac disease (CD) reported lower health-related quality of life (HRQOL) when compared with healthy children with nonceliac gastrointestinal (GI) complaints, according to a study published in the Journal of Pediatric Gastroenterology & Nutrition. CD is a common chronic condition associated with broad range of physical and psychosocial problems. In this…
Dual therapy with intravenous metronidazole and oral vancomycin is not superior to oral vancomycin alone in the treatment of Clostridioides difficile infections.
In the field of hospital epidemiology, there is a need for higher-quality trials that demonstrate more conclusive results, which in turn require larger sample sizes.
